🔧 Filters
Try: author name · keyword phrase · DOI
Case Series
Dermatofibrosarcoma protuberans is an uncommon cutaneous tumor that originates from the dermal fibroblasts. Dermatofibrosarcoma protuberans can develop in various parts of the body. However, it is rar
Dermatofibrosarcoma protuberans (DFSP)Breast cancer.
Original Article
Breast tumours are abnormal growths in breast tissue. They can be benign or malignant. Breast cancer is the second most common type of cancer that leads to death globally. In Sudan, it is the most com
Breast CancerMalignancyBreast TumorAlcian BluePASHistopathology
Review Article
Background: The Fine Needle Aspiration Cytology (FNAC) and Tru-Cut Biopsy (TCB) are significant investigative techniques used to differentiate breast issues. There is much research done on how well th
FNACTru-Cut BiopsyBreast CancerDiagnostic AccuracySystematic Review
Original Article
Introduction: Chronic inflammation has shown to have a recognized part in carcinogenesis, influencing tumor initiation, development, and prognosis. In breast carcinoma, systemic inflammatory markers s
Breast cancerCRPIL-8TNF-αlymphovascular invasion
Original Article
The breast is a rare location for the development of a malignant lymphoma with the incidence of Primary breast lymphoma (PBL) being less than 0.5% of all breast malignancies and 2% of all extranodal l
Breast LymphomaExtranodalDLBCLImmunohistochemistryChemotherapy
Original Article
Objective: Breast lesions encompass a broad spectrum of pathological conditions requiring accurate diagnosis and classification for appropriate management. Methods: This hospital-based descriptive stu
Breast CancerER/PRHER2/neuHistopathologyMolecular Subtypes.
Review Article
Background: Oestrogen and oestrogen-modulating therapies remain central to women’s health, yet their associations with cancer, cardiovascular outcomes, and fibroid disease continue to be debated. The
oestrogenhormone replacement therapybreast cancerovarian cancerendometrial canceruterine fibroids
Review Article
Background: The perioperative period is a "vulnerable window" where surgical stress and anesthetic choice may influence long-term oncological prognosis. This review evaluates the impact of anesthetic
Breast cancer surgeryAnesthetic modalitiesOncological outcomesImmune modulation